COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1382: Articles 13811-13820  | Next

SARS-CoV-2-Triggered Mast Cell Rapid Degranulation Induces Alveolar Epithelial Inflammation and Lung Injury
Wu, M.-L., Liu, F.-L., Sun, J., Li, X., He, X.-Y., Zheng, H.-Y., Pei, R.-J., Sun, H., Zhou, Y.-H., Yan, Q.-H., Wu, C.-X., Chen, L., Yu, G.-Y., Chang, J., Jin, X., Zhao, J., Chen, X.-W., Zheng, Y.-T., Wang, J.-H.
10.1101/2021.06.24.449680 — Posted: 2021-06-24
The impact of legislation on Covid-19 mortality in a Brazilian federative unit was mediated by social isolation.
Diaz-Quijano, F. A., Ribeiro, T. B., da Rosa, A. V., Reis, R., Aith, F., Ventura, D. F. L.
10.1101/2021.06.16.21259057 — Posted: 2021-06-24
OVARIAN GRANULOSA CELLS FROM WOMEN WITH PCOS EXPRESS LOW LEVELS OF SARS-COV-2 RECEPTORS AND CO-FACTORS
Naigaonkar, A. A., Patil, K. M., Joseph, S., Hinduja, I., Mukherjee, S.
10.1101/2021.06.15.21259003 — Posted: 2021-06-24
The effect of Health Literacy on COVID-19 Vaccine Hesitancy: The Moderating Role of Stress
Zhang, F., Zhang, H., Li, Y., Peng, S., Jiang, Y., Jin, H.
10.1101/2021.06.16.21258808 — Posted: 2021-06-24
Optimal Selection of COVID-19 Vaccination Sites at the Municipal Level
Cabanilla, K. I. M., Enriquez, E. A. T., Mendoza, R., Mendoza, V. M. P.
10.1101/2021.06.20.21259194 — Posted: 2021-06-24
Delay of molecular SARS-CoV-2 testing and turnaround time in Mexico and Colombia
Nunez, I., Belaunzaran-Zamudio, P. F., Caro-Vega, Y.
10.1101/2021.06.16.21259046 — Posted: 2021-06-24 Discussion: Onsite
Population disruption: estimating changes in population distribution in the UK during the COVID-19 pandemic
Gibbs, H., Waterlow, N. R., Cheshire, J., Danon, L., Liu, Y., Grundy, C., Kucharski, A. J., LSHTM CMMID COVID-19 Working Group, , Eggo, R. M.
10.1101/2021.06.22.21259336 — Posted: 2021-06-24
Correlates of Protection against symptomatic and asymptomatic SARS-CoV-2 infection
Feng, S., Phillips, D., White, T., Sayal, H., Aley, P. K., Bibi, S., Dold, C., Fuskova, M., Gilbert, S. C., Hirsch, I., Humphries, H. E., Jepson, B., Kelly, E. J., Plested, E., Shoemaker, K., Thomas, K. M., Vekemans, J., Villafana, T. L., Lambe, T., Pollard, A. J., Voysey, M., Oxford Vaccine Trial Team
10.1101/2021.06.21.21258528 — Posted: 2021-06-24 Discussion: Onsite
Trends in COVID-19 vaccination intent, determinants and reasons for vaccine hesitancy: results from repeated cross-sectional surveys in the adult general population of Greece during November 2020-June 2021
Sypsa, V., Roussos, S., Engeli, V., Paraskevis, D., Tsiodras, S., Hatzakis, A.
10.1101/2021.06.23.21259376 — Posted: 2021-06-24
Selective tweeting of COVID-19 articles: Does title or abstract positivity influence dissemination?
Fabiano, N., Hallgrimson, Z., Wong, S., Salameh, J.-P., Kazi, S., Unni, R. R., Treanor, L., Frank, R., Prager, R., McInnes, M. D.
10.1101/2021.06.22.21259354 — Posted: 2021-06-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).